Evaluation of Antihyperlipidemic and Antidiabetic Activity of Phyllanthus emblica L. Fruits 

Masfria Masfria1,2*, Mukhlisyam Mukhlisyam1, Yade M. Permata1, Faizar Faizar
1Pharmaceutical Chemistry Department, Faculty of Pharmacy, Universitas Sumatera Utara, Medan 20155, Indonesia
2Nanomedicine Centre of Inovation, Universitas Sumatera Utara, Medan 20155, Indonesia


Corresponding Author: masfria@usu.ac.id; Tel: +6285275929233
Recieved Date: 19 January 2021; Accepted Date: 18 April 2021; Published Date: 03 May
Citation: Masfria M, Mukhlisyam M, Permata YM, Faizar F. Evaluation of Antihyperlipidemic and Antidiabetic Activity of Phyllanthus emblica L. fruits. Trop J Nat Prod Res. 2020; 5(4): 668-672. doi.org/10.26538/tjnpr/v5i4.13 http://www.doi.org/10.26538/tjnpr/v5i4.13
Copyright:
© 2021 Masfria et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Visit for more related articles at  Tropical Journal of Natural Product Research




ABSTRACT

Phyllanthus emblica L. fruit is used traditionally as medicine for diarrhea, thrush, and cholesterol and it has been studied that Phyllanthus emblica L. fruit have various secondary metabolites such as alkaloids, saponins, flavonoids, tannins, steroids/triterpenoids, glycosides and it also contains high vitamin C, which has anti-cholesterol and anti-diabetic effect. The purpose of the research was to evaluate the anti-cholesterol and anti-diabetic activity of ethanol extract of P. emblica fruit. The extract was obtained by percolation with 96% ethanol solvent. The anti-cholesterol activity was carried out using the Lieberman-Burchard method while the anti-diabetic activity was assessed using the alpha-glucosidase inhibitory activity assay. The determination of the anti-cholesterol activity of the ethanol extract of P. emblica, fenofibrate and simvastatin was carried out at serial concentrations (12.5; 15; 17.5; 20; and 22.5 µg/mL). Ethanol extract of P. emblica fruit reduce cholesterol level by 67.2608; 68.6076; 69.9194; 72.0773 and 73.4992% at 12.5; 15; 17.5; 20; and 22.5 µg/mL, respectively. Fenofibrate showed anti-cholesterol activity with percentage reduction of 58.9696; 61.3529; 62.5344; 64.1717 and 65.8890% while Simvastatin showed anti-cholesterol activity with percentage reduction of 61.1326; 65.0278; 69.2285; 73.3339 and 76.3781% at 12.5; 15; 17.5; 20; and 22.5 µg/mL, respectively. The IC50 values for alpha-glucosidase inhibition for P. emblica extract, acarbose and quercetin were 4.5833; 9.6862 and 2.4850 µg/mL, respectively. It can be concluded that the ethanol extract of P. emblica fruit has anti-cholesterol activity that is similar to simvastatin and it showed higher activity than fenofibrate and it also showed higher antidiabetic activity than acarbose.

Keywords: Anticholesterol, Antidiabetic, Ethanol extracts, Phyllanthus emblica L., Lieberman Burchard, Spectrophotometry
Back to Articles

ISSN: 2616-0684 (Print)
ISSN: 2616-0692 (Online)
DOI: 10.26538/tjnpr
Index Copernicus Value (ICV) for 2017: 59.83
Scopus citescore 0.3 (2020)

Indexing & Abstracting

citescore 0.3 (2020)

j-gate logo

International Innovative Journal Impact Factor

African Index Medicus

CAS

Index Copernicus International

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License

Crossref Content Registration logo

WorldCat Discovery Service

Geneva Foundation for Medical Education and Research